These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
517 related articles for article (PubMed ID: 30272351)
1. TRIM14 promotes the migration and invasion of gastric cancer by regulating epithelial‑to‑mesenchymal transition via activation of AKT signaling regulated by miR‑195‑5p. Wang F; Ruan L; Yang J; Zhao Q; Wei W Oncol Rep; 2018 Dec; 40(6):3273-3284. PubMed ID: 30272351 [TBL] [Abstract][Full Text] [Related]
2. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway. Xu G; Guo Y; Xu D; Wang Y; Shen Y; Wang F; Lv Y; Song F; Jiang D; Zhang Y; Lou Y; Meng Y; Yang Y; Kang Y Sci Rep; 2017 Feb; 7():42411. PubMed ID: 28205534 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer. Xu M; Qin S; Cao F; Ding S; Li M Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929 [TBL] [Abstract][Full Text] [Related]
4. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT. Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851 [TBL] [Abstract][Full Text] [Related]
5. ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling. Xu SH; Huang JZ; Xu ML; Yu G; Yin XF; Chen D; Yan GR J Pathol; 2015 Jun; 236(2):175-85. PubMed ID: 25678401 [TBL] [Abstract][Full Text] [Related]
6. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway. Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138 [TBL] [Abstract][Full Text] [Related]
7. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway. Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349 [TBL] [Abstract][Full Text] [Related]
8. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer. Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547 [TBL] [Abstract][Full Text] [Related]
9. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2. He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784 [TBL] [Abstract][Full Text] [Related]
10. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling. Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429 [TBL] [Abstract][Full Text] [Related]
11. LRP4 promotes migration and invasion of gastric cancer under the regulation of microRNA-140-5p. Mao Z; Wang Z; Zhang S; Pu Y; Wang J; Zhang T; Long Y; Liu Y; Ma Y; Zhu J Cancer Biomark; 2020; 29(2):245-253. PubMed ID: 32675391 [TBL] [Abstract][Full Text] [Related]
12. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway. Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131 [TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells. Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379 [TBL] [Abstract][Full Text] [Related]
14. Upregulated β-arrestin1 predicts poor prognosis and promotes metastasis via AKT/ERK signaling pathway in gastric cancer. Xu T; Shen G; Cheng M; Wu X; Xu Y; Hu S Pathol Res Pract; 2020 Dec; 216(12):153262. PubMed ID: 33129195 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
16. MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer. Zhang P; Tang WM; Zhang H; Li YQ; Peng Y; Wang J; Liu GN; Huang XT; Zhao JJ; Li G; Li AM; Bai Y; Chen Y; Ren YX; Li GX; Wang YD; Liu SD; Wang JD Br J Cancer; 2017 Aug; 117(4):525-534. PubMed ID: 28632723 [TBL] [Abstract][Full Text] [Related]
17. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway. Wei S; Wang L; Zhang L; Li B; Li Z; Zhang Q; Wang J; Chen L; Sun G; Li Q; Xu H; Zhang D; Xu Z Tumour Biol; 2016 Sep; 37(9):12813-12821. PubMed ID: 27449034 [TBL] [Abstract][Full Text] [Related]
18. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway. Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047 [TBL] [Abstract][Full Text] [Related]
19. TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4. Wei CY; Wang L; Zhu MX; Deng XY; Wang DH; Zhang SM; Ying JH; Yuan X; Wang Q; Xuan TF; He AQ; Qi FZ; Gu JY J Exp Clin Cancer Res; 2019 Mar; 38(1):137. PubMed ID: 30922374 [TBL] [Abstract][Full Text] [Related]
20. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer. Lu WD; Zuo Y; Xu Z; Zhang M World J Gastroenterol; 2015 Apr; 21(15):4564-73. PubMed ID: 25914465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]